Feasibility of an intervention for men on androgen deprivation therapy: A research protocol.
Adult
Aged
Aged, 80 and over
Androgen Antagonists
/ adverse effects
Behavior Therapy
/ methods
Cardiovascular Diseases
/ chemically induced
Diet, Healthy
/ methods
Exercise Therapy
/ methods
Feasibility Studies
Healthy Lifestyle
Humans
Male
Middle Aged
Pilot Projects
Prostatic Neoplasms
/ therapy
Quality of Life
Telemedicine
/ methods
United States
cancer
exercise
lifestyle change
nutrition
quality of life
Journal
Research in nursing & health
ISSN: 1098-240X
Titre abrégé: Res Nurs Health
Pays: United States
ID NLM: 7806136
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
13
05
2019
accepted:
20
07
2019
pubmed:
8
8
2019
medline:
12
11
2019
entrez:
8
8
2019
Statut:
ppublish
Résumé
Androgen deprivation therapy (ADT) is a treatment used across the prostate cancer disease spectrum and works by suppressing testicular androgen production to castrate levels. Although ADT can provide survival benefits, it is also associated with increased risk for cardiovascular disease, metabolic syndrome, increased visceral fat mass, dyslipidemia, decreased arterial compliance, and diminished health-related quality of life. The Staying Strong And Healthy protocol is a telephone-delivered intervention led by a nurse coordinator to minimize the increased cardiovascular and metabolic risks associated with ADT. This study will evaluate the feasibility of the protocol and provides the foundation for future behavioral interventions across diverse populations of men on ADT.
Identifiants
pubmed: 31389621
doi: 10.1002/nur.21977
pmc: PMC6767619
mid: NIHMS1051919
doi:
Substances chimiques
Androgen Antagonists
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
324-333Subventions
Organisme : NCI NIH HHS
ID : P30 CA168524
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR014518
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002366
Pays : United States
Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
J Clin Oncol. 2005 Jun 1;23(16):3830-42
pubmed: 15923576
CA Cancer J Clin. 2010 May-Jun;60(3):194-201
pubmed: 20124400
BJU Int. 2015 Feb;115(2):256-66
pubmed: 24467669
Eur Urol. 2014 May;65(5):865-72
pubmed: 24119318
Crit Rev Oncol Hematol. 2008 Nov;68(2):172-7
pubmed: 18706829
J Health Care Poor Underserved. 2008 Feb;19(1):200-14
pubmed: 18263996
Qual Health Res. 2008 Dec;18(12):1609-20
pubmed: 18955461
Nutrients. 2017 Sep 12;9(9):
pubmed: 28895922
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):647-57
pubmed: 21335510
Prostate Cancer Prostatic Dis. 2012 Sep;15(3):237-43
pubmed: 22289781
Prostate Cancer. 2014;2014:230812
pubmed: 24864213
Medicine (Baltimore). 2017 Jul;96(27):e7368
pubmed: 28682886
Eur Urol. 2013 Dec;64(6):905-15
pubmed: 23721958
Epidemiol Health. 2014 Jul 22;36:e2014009
pubmed: 25078382
Cancer. 2009 Jun 1;115(11):2388-99
pubmed: 19399748
J Clin Oncol. 2010 Jul 20;28(21):3448-56
pubmed: 20567006
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2960-84
pubmed: 24239922
Med Sci Sports Exerc. 2017 Aug;49(8):1503-1510
pubmed: 28319589
BJU Int. 2016 Jun;117(6B):E36-45
pubmed: 25959859
Health Educ Behav. 2004 Apr;31(2):143-64
pubmed: 15090118
J Clin Oncol. 2015 Jun 20;33(18):2021-7
pubmed: 25964245
Adv Urol. 2012;2012:978531
pubmed: 22461790
Soc Sci Med. 2016 May;156:80-9
pubmed: 27019142
Cancer. 2005 Apr 15;103(8):1615-24
pubmed: 15742331
Proc Nutr Soc. 2008 Aug;67(3):253-6
pubmed: 18452640
Eur Urol. 2012 Jan;61(1):11-25
pubmed: 21871711
JAMA. 2005 Jul 13;294(2):238-44
pubmed: 16014598
J Clin Oncol. 2009 Feb 1;27(4):634-6
pubmed: 19103726
Cancer. 2015 Jul 15;121(14):2350-7
pubmed: 25809861
Clin Cancer Res. 2004 Nov 15;10(22):7575-82
pubmed: 15569988
Cancer. 2015 Dec 15;121(24):4286-99
pubmed: 26372364
Psychooncology. 2015 Apr;24(4):472-7
pubmed: 24924331
Prostate Cancer Prostatic Dis. 2019 Sep;22(3):428-437
pubmed: 30664736
Eur Urol. 2015 May;67(5):825-36
pubmed: 25097095
Res Social Adm Pharm. 2018 Nov;14(11):1080-1084
pubmed: 29366669
J Clin Oncol. 2010 Jan 10;28(2):340-7
pubmed: 19949016
J Natl Cancer Inst. 2012 Oct 3;104(19):1518-23
pubmed: 23210129
J Cancer Surviv. 2015 Sep;9(3):431-40
pubmed: 25916660
Cancer. 2014 Jan 15;120(2):294-301
pubmed: 24122296
Urol Int. 2013;90(1):41-4
pubmed: 23235105
J Clin Oncol. 2003 May 1;21(9):1653-9
pubmed: 12721238